Related Experiment Videos
Hypertrophic cardiomyopathy: from gene defect to clinical disease
Man-Wei Chung1, Tatiana Tsoutsman, Christopher Semsarian
1Molecular Cardiology Group, Centenary Institute, Royal Prince Alfred Hospital, Sydney, NSW, Australia.
Insights
Genetic defects in sarcomere proteins cause hypertrophic cardiomyopathy (HCM), a leading cause of sudden death in young adults. Research is uncovering how these gene mutations lead to disease and identifying modifying factors.
Area of Science:
- Cardiovascular Medicine
- Genetics
- Molecular Biology
Background:
- Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiac disorder.
- It is a leading cause of sudden cardiac death in individuals under 35, including athletes.
- Genetic mutations affecting sarcomere proteins are known to cause HCM.
Purpose of the Study:
- To understand the molecular mechanisms underlying HCM.
- To identify factors that modify the expression of disease-causing genes.
- To explore novel therapeutic targets for cardiovascular disease.
Main Methods:
- Utilizing cell culture models.
- Employing animal models of HCM.
- Investigating signaling pathways involved in disease pathogenesis.
Main Results:
- Identified at least ten genes associated with HCM, all encoding sarcomere proteins.
- Gained insights into signaling pathways implicated in HCM.
- Beginning to understand the role of environmental and genetic modifiers.
Conclusions:
- Further research into HCM mechanisms is crucial for advancing cardiovascular disease treatment.
- Understanding gene-defect-disease relationships can lead to new therapeutic strategies.
- Advances in HCM research enhance knowledge of heart muscle biology.
Abstract:
Major advances have been made over the last decade in our understanding of the molecular basis of several cardiac conditions. Hypertrophic cardiomyopathy (HCM) was the first cardiac disorder in which a genetic basis was identified and as such, has acted as a paradigm for the study of an inherited cardiac disorder. HCM can result in clinical symptoms ranging from no symptoms to severe heart failure and premature sudden death. HCM is the commonest cause of sudden death in those aged less than 35 years, including competitive athletes. At least ten genes have now been identified, defects in which cause HCM. All of these genes encode proteins which comprise the basic contractile unit of the heart, i.e. the sarcomere. While much is now known about which genes cause disease and the various clinical presentations, very little is known about how these gene defects cause disease, and what factors modify the expression of the mutant genes. Studies in both cell culture and animal models of HCM are now beginning to shed light on the signalling pathways involved in HCM, and the role of both environmental and genetic modifying factors. Understanding these mechanisms will ultimately improve our knowledge of the basic biology of heart muscle function, and will therefore provide new avenues for treating cardiovascular disease in man.